Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


SpectraMax® i3: When is the last time you inspected your cells and ran an assay on the same instrument?

Product Image
Product Description

The SpectraMax® i3 is Molecular Devices latest multi-mode microplate reader which delivers several applications including; Ultra-Violet to visible absorbance detection, fluorescence intensity and multi-colour luminescence. There is the option to add user-installable cartridges as your research needs evolve including HTRF®, AlphaScreen® and Fluorescence Polarisation assays as well as cellular imaging, (with the SpectraMax® MiniMax™) increasing the instruments flexibility. This highly sensitive instrument accommodates the budget and throughput needs of both small and large laboratories alike.

The SpectraMax® i3 Platform's base system features an integrated optical system which enables both top and bottom reads for 6-, 384- well microplates and launches with three broad detection modes: luminescence, absorbance, and fluorescence. The patented user-exchangeable cartridge design expands the system's detection capability making it highly versatile, and able to offer application options far exceeding those of standard readers.

Using a combination of a flash lamp for spectral flexibility and light emitting diodes (LEDs) for excitation power, Molecular Devices has developed the patent-pending Spectral Fusion™ Illumination to deliver wavelength flexibility whilst maximizing signal strength, ultimately increasing overall performance.

Data from the SpectraMax® i3 System is captured and analysed using Molecular Devices' proprietary, industry-leading SoftMax® Pro Software. The newly updated interface and Spectral Optimization Wizard simplifies the workflow and provides powerful data analysis features, eliminating the need for training on additional software. The SpectraMax® i3 System is also available for use in GMP and GLP labs when used with the SoftMax® Pro 6.3 GxP Microplate Data Compliance Software. This new user interface and powerful data analysis package simplifies the set-up of the SpectraMax® i3 platform, getting you to your results much faster!

SpectraMax® MiniMax™ Imaging Cytometer

When is the last time you inspected your cells and ran an assay on the same instrument? With the user-upgradable imaging cytometer option, turn your SpectraMax® i3 microplate reader into a cellular imager and unlock a new world of applications. 

The MiniMax™ Imaging Cytometer module adds first of its kind cellular imaging to a multi-mode detection platform, enabling fluorescence and bright field cellular imaging. Combining cellular imaging with microplate-based applications offers new ways for scientists to compress their workflows and increase efficiency. 

Key benefits include:

User Upgradeability:
Expand the 3-mode base system with additional application cartridges for FP, HTRF®, AlphaScreen® assays and cellular imaging. These user-installable cartridges prevent the need for system down time or service engineers. 

SpectraMax® MiniMax™ Imaging Cytometer:
Simplifies complex imaging workflows by visualising cell morphology changes on top of well-based intensity readings

Spectral Fusion™ Illumination:
Delivers high-powered full spectrum light source for increased fluorescence performance across the entire excitation range

Expanded Dynamic Range:
Sophisticated engineering delivers optimal sensitivity and maximises signal range 

Imagine the SpectraMax® i3 in your lab today and begin to realise what this system will bring to your research!

For more information on the SpectraMax® i3 and SpectraMax® MiniMax™ and to see a video of them in action CLICK HERE

Product SpectraMax® i3: When is the last time you inspected your cells and ran an assay on the same instrument?
Company Molecular Devices
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Molecular Devices
660 - 665 Eskdale Road Winnersh Triangle Wokingham Berkshire RG41 5TS

Tel: +44-118-944-8000
Fax: +44-118-944-8001
Email: infoboxeu@moldev.com



Scientific News
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
New Strategy for Combating Adenoviruses
Using an animal model they developed, Saint Louis University and Utah State university researchers have identified a strategy that could keep a common group of viruses called adenoviruses from replicating and causing sickness in humans.
Major Advance Toward More Effective, Long-Lasting Flu Vaccine
Collaboration shows vaccine candidate can produce powerful ‘broadly neutralizing antibodies’ in animal models.
Immune System: Help for Killer Cells
A study from the University of Bonn may show the way to more effective vaccines.
Protein Found to Control Inflammatory Response
A new Northwestern Medicine study shows that a protein called POP1 prevents severe inflammation and, potentially, diseases caused by excessive inflammatory responses.
A Leap Forward in Vaccinating Against HIV
A team of scientists has developed an experimental vaccine candidate that successfully stimulates the immune system activity in animal models necessary to stop HIV infection.
MRI Scanners Can Steer Therapeutics to Specific Target Sites
Scientists from the University of Sheffield have discovered MRI scanners, normally used to produce images, can steer cell-based, tumour busting therapies to specific target sites in the body.
Agricultural Intervention Improves HIV Outcomes
A multifaceted farming intervention can reduce food insecurity while improving HIV outcomes in patients in Kenya, according to a randomized, controlled trial led by researchers at UC San Francisco.
Team Finds Early Inflammatory Response Paralyzes T Cells
Findings could have enormous implications for immunotherapy, autoimmune disorders, transplants and other aspects of immunity.

SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!